New online resource – www.KeepHerAwesome.com – educates about bacterial vaginosis (BV), the most prevalent gynecologic infection in the U.S., and other women’s health issues  

 New national survey reveals the serious impact BV has on women

 Newark, NJ, November 9, 2017 – Roshini Raj, MD, a board-certified physician and women’s health advocate, author and medical correspondent and Shannon Boodram, AKA Shan Boody, a clinical sexologist and author, have teamed up with Symbiomix Therapeutics, LLC, a Lupin Company, to launch Keep Her Awesome, a national awareness campaign focused on educating and empowering women to take control of their gynecologic health. The new resource provides consumers and healthcare professionals with information on critical women’s health issues that too often go unnoticed, related misperceptions, and the importance of proactively speaking with a healthcare provider and taking charge of a woman’s gynecologic health.

According to a new national survey conducted online by Harris Poll on behalf of Symbiomix Therapeutics and the American Sexual Health Association (ASHA) of 304 U.S. women aged 18 to 49 who have been diagnosed by a healthcare professional with BV within the past two years, 76 percent stated they would have gone to see a healthcare professional sooner if they were aware of the risks associated with BV if left untreated. Additionally, not only did more than three in five women with BV (62 percent) mistake it for a yeast infection before diagnosis, but one in five (20 percent) still believe that BV is a yeast infection. [1]

BV affects 21 million women ages 14 to 49 annually. However, women of any age can get BV, even if they have never had sex. Common signs and symptoms associated with BV include unusual vaginal discharge that can be white or gray; watery; or have a strong fish-like odor. If left untreated, BV increases the risk of transmission of sexually transmitted infections, including chlamydia, trichomaniasis, gonorrhea, herpes and HIV BV also increases the risk of pre-term birth and low birth weight; and pelvic inflammatory disease. [2,3]

“It can be difficult to tell common gynecologic infections from one another because the symptoms can be similar,” said Roshini Raj, MD. “However, if ignored or mistreated, gynecologic infections can increase the risk of serious health concerns. Over-the-counter or holistic remedies do not effectively treat some gynecologic infections; several can only be treated properly with a prescription antibiotic, which is why it’s important to visit a healthcare provider.”

BV and gynecologic infections don’t just affect women’s physical health. They can also impact women’s emotional health. [4] Results from the national survey found that many women with BV feel self-conscious (68 percent) and/or embarrassed (66 percent) due to their condition. In fact, women with BV admit that they have avoided certain everyday activities that may often be taken for granted, including being intimate with their spouse/partner (79 percent), working out (27 percent), going on a first date (17 percent), performing everyday activities (e.g. running errands, doing chores) (16 percent), and spending time with family/friends (15 percent). [1]

“These survey results reaffirm what we hear from women affected by BV – the impact goes beyond the physical symptoms. BV can greatly impact women’s emotional health as well, causing feelings of anxiety and embarrassment that can influence healthy sex lives, dating and personal relationships,” said Deborah Arrindell, Vice President of Health Policy, American Sexual Health Association. “It’s important for women to know their bodies, and to proactively speak with their healthcare provider when something doesn’t seem right.”

Visit www.KeepHerAwesome.com to learn more about women’s health issues, additional results from the national survey and how women can take control of their gynecologic health.

 About the Survey

The survey was conducted online by Harris Poll on behalf of Symbiomix Therapeutics, LLC, a Lupin Company, and the American Sexual Health Association (ASHA) within the United States between September 14 and 29, 2017 among 304 U.S. women aged 18 to 49 who have been diagnosed by a healthcare professional with bacterial vaginosis (BV) within the past 2 years (“women with bacterial vaginosis”). Figures for age, income, race/ethnicity, region, education, and size of household were weighted where necessary to bring them into line with their actual proportions in the population.

 About the American Sexual Health Association

The American Sexual Health Association (ASHA) is a not-for-profit organization founded in 1914 to improve the health of individuals, families, and communities, with a focus on educating about and preventing sexually transmitted diseases. ASHA’s educational web sites include: www.ashasexualhealth.org, www.iwannaknow.org (teen site), and www.quierosaber.org (Spanish language site).

 About Symbiomix Therapeutics, LLC

Symbiomix (sim-bye-OH-mix) Therapeutics, a Lupin Company, is a biopharmaceutical company focused exclusively on bringing innovative therapies to market for prevalent gynecologic infections that can have serious health consequences.

Symbiomix was founded in 2012 and acquired by Lupin Inc. in 2017. Please visit https://symbiomix.com/ and follow the Company on LinkedIn and Twitter for more information.

© 2017-Symbiomix Therapeutics LLC, A Lupin Company

Media Contacts:

Becky Vonsiatsky

O: 415.946.1080

M: 413.478.2003

bvonsiatsky@w2ogroup.com

REFERENCES

  1. Data on File.
  2. Koumans E.H., Sternberg M, Bruce C, et al. (2007). “The Prevalence of Bacterial Vaginosis in the United States, 2001-2004: Associations with Symptoms, Sexual Behaviors, and Reproductive Health. Sex Transm Dis. 34(11): 864-869.
  3. https://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm.
  4. Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C et al: The Burden of Bacterial Vaginosis: Women’s Experience of the Physical, Emotional, Sexual and Social Impact of Living with Recurrent Bacterial Vaginosis. PLoS ONE 2013, 8(9): e74378. doi: 10.1371/journal.pone. 0074378 PMID: 24040236.